PD-145 Long-term survival of NSCLC patients with EGFR mutationstreated with EGFR TKIs gefitinib or erlotinib
Year: 2005
Type: conference-abstract
Source: Lung Cancer
Authors: P. Janne, L. Sequist, N. Lindeman, D. Bell, M. Huberman, M. Meyerson, D. Haber, T. Lynch, B. Johnson
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1990806472